Atlas Trials

MRD-guided Treatment in NPM1mut AML Patients

Clinical trial NCT03769532 · TERMINATED

Trial details

NCT number
NCT03769532
Sponsor
Technische Universität Dresden
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2019-08-21
Primary completion
2025-02-13
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.